All News
Filter News
Found 809,065 articles
-
preCARDIA, Inc. Receives FDA Breakthrough Device Designation for Novel, Catheter Based Heart Failure Treatment
6/23/2020
preCARDIA, Inc., has announced that the company's catheter based system for treating volume overload in patients with acutely decompensated heart failure (ADHF) has been designated for the Breakthrough Devices Program by the U.S
-
Waters Extends the Capability and Power of its High-Resolution Mass Spectrometers
6/23/2020
Enhancements for the Waters Xevo G2-XS QTof, SYNAPT XS and SELECT SERIES Cyclic IMS Instruments Accelerate Biomedical and Pharmaceutical Research MILFORD, Mass.--( BUSINESS WIRE )-- Waters Corporation (NYSE:WAT) announced today a new fragmentation technique and an imaging option for its high-resolution mass spectrometers giving research scientists working across a broad range of end markets including biomedical, biopharmaceutical and food research, g
-
Waters Introduces the New Arc High-Performance Liquid Chromatograph to Help Laboratories Meet Quality and Production Targets
6/23/2020
Modern LC System Replicates Established Test Methods, Delivers Improved Performance; Updates to Lab Business Continuity Solution Also Announced
-
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2020 After Market Close on June 30, 2020
6/23/2020
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the quarter and fiscal year (FY) ended April 30, 2020
-
LGC Maine Standards announces VALIDATE® ACTH kit for Roche cobas® with easy, fast, and reliable documentation of linearity, calibration verification, and Analytical Measurement Range (AMR) verification
6/23/2020
LGC Maine Standards¹ announces the release of VALIDATE ® ACTH Linearity and Calibration Verification Test Kits for easy, fast, and reliable documentation of linearity, calibration verification, and Analytical Measurement Range (AMR) verification of Adrenocorticotropic Hormone (ACTH). The product (Order No. 302MM) is formu
-
Genetic Technologies CEO to Participate in Investor Webinar and Q&A Session on June 24, 2020
6/23/2020
Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”) is pleased to announce that its interim-CEO Dr. George Muchnicki will share insight into the Company’s recent developments during an investor webinar, hosted by RedChip Companies, on Wednesday, June 24, 2020 at 4:00 p.m. ET. A live Q&A session with Dr. Muchnicki will follow the presentation.
-
U.S. Department of Veterans Affairs Successfully "Goes Live" With Prodigo's Marketplace Solution
6/23/2020
Prodigo Solutions is pleased to announce that the Veterans Affairs (VA), the largest integrated healthcare network in the United States , with 1,255 health care facilities serving 9 million enrolled Veterans each year, has successfully launched Prodigo's Marketplace as of Monday, June 8th . Marketplace is Prodigo's flagship product
-
HTG EdgeSeq Technology Highlighted in Multiple Posters Presented by Pharma Partners at the 2020 American Association for Cancer Research Virtual Meeting
6/23/2020
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced its HTG EdgeSeq technology was highlighted in multiple posters presented by global pharma company partners at the American Association for Cancer Research (AACR) 2020 Virtual Meeting.
-
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
6/23/2020
Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering
-
Northeast Scientific Inc. Wins 510(k) for IVUS Catheter Reprocessing
6/23/2020
Northeast Scientific Inc., this week announced it has received FDA clearance for reprocessing the .014 Digital IVUS catheter. This is the second 510(k) the Connecticut based company has been awarded for the reprocessing of the IVUS type catheter. While crediting his team in their work addressing the FDA requirements to win the 510(k), CEO Craig Allmendinger went on to say; “By adding the .014 IVUS to our existing portfolio of products, we a
-
Health and Human Services Selects Geospark Analytics for Development of Artificial Intelligence Disease Outbreak Modeling
6/23/2020
Geospark Analytics, the world class leader in developing applied artificial intelligence (AI) solutions for global threat and risk assessment, was just awarded a five-year, multi-million dollar contract with the U.S. Department of Health and Human Services (HHS) for use of the company's Hyperion platform, its COVID-19 risk model, and development of new AI-driven disease outbreak models.
-
FDA Announces First of Its Kind Pilot Program to Communicate Patient Reported Outcomes from Cancer Clinical Trials
6/23/2020
The U.S. Food and Drug Administration today launched Project Patient Voice, an initiative of the FDA's Oncology Center of Excellence (OCE).
-
Oppilan Pharma Announces Positive Phase 1 Data for its Ulcerative Colitis Drug OPL-002 at Digestive Disease Week 2020 Virtual Scientific Program
6/23/2020
Potential best-in-class profile for an oral sphingosine-1-phosphate receptor modulator - Dose-dependent reduction in circulating lymphocytes - - Rapid lymphocyte recovery after cessation of dosing - - Phase 2 study in ulcerative colitis patients in 4Q 2020 - ENCINITAS, Calif. and CAMBRIDGE, United Kingdom, June 23, 2020 (GLOBE NEWSWIRE) -- Oppilan Pharma, Ltd., a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics for the treatment o
-
Quest Diagnostics to Expand in Indiana with Acquisition of Outreach Lab Businesses of Community Health Network and Ascension St. Vincent Now Serviced Through Mid America Clinical Laboratories
6/23/2020
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the formation of a definitive multi-pronged agreement designed to optimize the delivery of high quality, innovative diagnostic laboratory services in Indiana.
-
SASpine and Dr. Cyr Recognized with Vitals Patient Awards
6/23/2020
SASpine and Dr. Steven Cyr receive 3 distinguished awards from patients through Vitals, an unsponsored, unbiased patient rating system.
-
Draper Demonstrates Miniature Organ Models Can Play Key Role in COVID-19 Drug Development
6/23/2020
Draper today announced the release of a new scientific article that describes how the company’s technology can be used to test an in vitro human lung model to investigate responses following infection with COVID-19 and influenza.
-
Praxis Bioresearch Announces Issuance of U.S. Patent on its Prodrug Stimulant PRX-P4-003
6/23/2020
Praxis Bioresearch, a biopharmaceutical company focused on the discovery and development of novel therapeutics for chronic central nervous system disorders, today announced that it has been issued a new patent (US Patent 10,662,146) by the United States Patent and Trademark Office covering pharmaceutical compositions comprising fencamfamine prodrug derivatives. The patent will remain in effect until September 13, 2036. Separately, the compa
-
Carlsmed Raises $2.5M to Improve Complex Spine Surgery
6/23/2020
- The round was led by Cove Fund II, a prominent Life Science and Tech VC fund. - Funds will be deployed to commercialize its data driven surgery mission. - Carlsmed expands team of executive officers adding CFO and CIO. SAN DIEGO--( BUSINESS WIRE )-- Carlsmed, Inc., a San Diego-based MedTech company, today announced the close of an oversubscribed $2.5M seed round. The round was led by Cove Fund II, a prominent California Life Science and Technolog
-
Neuraptive Therapeutics Appoints Robert S. Radie as Chief Executive Officer and Chairman of the Board
6/23/2020
Neuraptive Therapeutics, Inc. (Neuraptive), a clinical-stage biotechnology company dedicated to developing novel therapeutics and medical products for the treatment of peripheral nerve injuries (PNI), today announced the hiring of Robert (Bob) S. Radie as Chief Executive Officer.
-
Life Science Industry in California Generates $372 Billion Annually, Providing 1.4M Jobs
6/23/2020
California’s life science industry provides over 1.4 million jobs in the region, with economic activity generating a total of $372 billion in 2019 alone.